A mutant androgen receptor from patients with Reifenstein syndrome: identification of the function of a conserved alanine residue in the D box of steroid receptors.

по Kaspar, F, Klocker, H, Denninger, A, Cato, A C
Опубликовано 1993

Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer

по Massoner, P, Ladurner-Rennau, M, Eder, I E, Klocker, H
Опубликовано 2010

Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome.

по Klocker, H, Kaspar, F, Eberle, J, Uberreiter, S, Radmayr, C, Bartsch, G
Опубликовано 1992

5-alpha-reductase and the development of the human prostate

по Radmayr, C., Lunacek, A., Schwentner, C., Oswald, J., Klocker, H., Bartsch, G.
Опубликовано 2008

DNA repair dependent NAD+ metabolism is impaired in cells from patients with Fanconi's anemia.

по Klocker, H, Auer, B, Hirsch-Kauffmann, M, Altmann, H, Burtscher, H J, Schweiger, M
Опубликовано 1983

ADP-ribosyltransferase from Helix pomatia. Purification and characterization.

по Burtscher, H J, Klocker, H, Schneider, R, Auer, B, Hirsch-Kauffmann, M, Schweiger, M
Опубликовано 1987

Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.

по Eder, I. E., Stenzl, A., Hobisch, A., Cronauer, M. V., Bartsch, G., Klocker, H.
Опубликовано 1997

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

по Cronauer, M V, Nessler-Menardi, C, Klocker, H, Maly, K, Hobisch, A, Bartsch, G, Culig, Z
Опубликовано 2000

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205

по Massoner, P, Thomm, T, Mack, B, Untergasser, G, Martowicz, A, Bobowski, K, Klocker, H, Gires, O, Puhr, M
Опубликовано 2014

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

по Culig, Z, Hoffmann, J, Erdel, M, Eder, I E, Hobisch, A, Hittmair, A, Bartsch, G, Utermann, G, Schneider, M R, Parczyk, K, Klocker, H
Опубликовано 1999

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

по Culig, Z., Hobisch, A., Herold, M., Hittmair, A., Thurnher, M., Eder, I. E., Cronauer, M. V., Rieser, C., Ramoner, R., Bartsch, G., Klocker, H., Konwalinka, G.
Опубликовано 1998

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer

по Schaefer, G, Mosquera, J-M, Ramoner, R, Park, K, Romanel, A, Steiner, E, Horninger, W, Bektic, J, Ladurner-Rennau, M, Rubin, M A, Demichelis, F, Klocker, H
Опубликовано 2013

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer

по Puhr, M, Hoefer, J, Eigentler, A, Dietrich, D, van Leenders, G, Uhl, B, Hoogland, M, Handle, F, Schlick, B, Neuwirt, H, Sailer, V, Kristiansen, G, Klocker, H, Culig, Z
Опубликовано в: Oncogene (2016)